The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1

Vaccine

Volumn 17, Issue 20-21, 1999, Pages 2517-2527

  Moore, Anne ^a   McCarthy, Leone ^a   Mills, Kingston H G ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Adjuvant; Monophosphoryl lipid A; Th1 cells

Indexed keywords

ALKALINE PHOSPHATASE; ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; PHOSPHORYL LIPID A; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; VIRUS PROTEIN;

ADJUVANT THERAPY; ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LIPID ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ANTIGENS, CD80; FEMALE; HIV ENVELOPE PROTEIN GP120; INTERFERON TYPE II; INTERLEUKIN-12; LIPID A; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; SAPONINS; TH1 CELLS; TH2 CELLS; VACCINES, SYNTHETIC;

EID: 0033522812     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00062-6     Document Type: Article

References (31)

1. Mills K.H.G. Induction and detection of T-cell responses. Robinson A., Farrar G., Wiblin C., Methods in molecular medicine, vaccine protocols. 1996;197-221 Humana Press Inc, Totowa, NJ.
2. + Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J Exp Med. 181:1995;1285-1292.
3. Mahon B.P., Ryan M.S., Griffin F., Mills K.H.G. Interleukin-12 is produced by macrophages on response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun. 64:1996;5295-5301.
4. + Th1 cells by immunization with recombinant gp120 entrapped in biodegradable microparticles. Vaccine. 13:1995;1741-1749.
5. Trinchieri G., Kubin M., Bellone G., Cassatella M.C. Cytokine crosstalk between phagocytic cells and lymphocytes, relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity. J Cell Biochem. 53:1993;301-308.
6. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;250-254.
7. Ziegler-Heitbrock H.W., Wedel A., Schraut W., Strobel M., Wendelgass P., Stenrnsdorf T., Bauerle P.A., Hass J.G., Riethmuller G. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kB with predominance of p50 homodimers. J Biol Chem. 269:1994;17001-17004.
8. Ishikawa Y., Mukaida N., Kuno K., Rice N., Okamoto S., Matsushima K. Establishment of lipopolysaccharide-dependent nuclear factor kappa B activation in a cell-free system. J Biol Chem. 270:1995;4158-4164.
9. Wysocka M., Kubin M., Vieira L., Ozmen L., Garotta G., Scott P., Trinchieri G. Interleukin-12 is required for interferon-gamma production and lethality in polysaccharide-induced shock in mice. Eur J Immunol. 25:1995;672-676.
10. Heufler C., Koch F., Stanzl U., Topar G., Wysocka M., Trinchieri G., Enk A., Steinmann R.M., Romani N., Schuler G. Interleukin-12 is produced by dendritic cells and mediates T-helper 1 development as well as interferon-γ production by T-helper 1 cells. Eur J Immunol. 26:1996;659-668.
11. Ribi E. Beneficial modification of the endotoxin molecule. J Biol Response Mod. 3:1984;1-9.
12. Ribi E. Structure-function relationship of bacterial adjuvants. Nervig R.M., Gough P.M., Kaeberle M.L., Whetstone C.A., Advances in carriers and adjuvants for veterniary biologicals. 1986;35-49 Iowa State University Press, Ames.
13. Gustafson G.L., Rhodes M.J. A rationale for the prophylactic use of monophosphoryl lipid A in sepsis and septic shock. Biochem Biophys Res Commun. 182:1992;269-275.
14. Ulrich J.T., Myers K.B. Monophosphoryl lipid A as an adjuvant past experiences and new directions. Powell M.F., Newman M.J., Vaccine design: the subunit and adjuvant approach. 1995;495-524 Plenum Press, New York.
15. + cytotoxic T-cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature. 344:1990;873-875.
16. Kensil C.R., Patel U., Lennick M., Marciani D. Seperation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. J Immunol. 146:1991;431-437.
17. Kensil C.K., Newman M.J., Couglin R.T., Soltysik S., Bedore D., Recchia J., Wu J., Marciani D.J. The use of Stimulon adjuvant to boost vaccine response. Vaccine Res. 2:1993;273-281.
18. Newman M.J., Wu J., Coughlin R.T., Murphy C.L., Seals J.R., Wyand M.S., Kensil C.R. Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates. AIDS Res Hu Retro. 8:1992;1413-1418.
19. Mooij P., van der Kolk M., Bogers W.M.J.M., ten Haaft P.J.F., Van Der Meide P., Almond N., Stott J., Deschamps M., Labbe D., Momin, Voss, Van Hoegen P., Bruck C., Heeney J.I. A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection. AIDS. 12:1998;F15-22.
20. Hathcock K., Laszlo G., Pucillo C., Linsley P., Hodes R. Comparative analysis of B7-1 and B7-2 costimulatory ligands, expression and function. J Exp Med. 180:1994;631-640.
21. Snijders A., Hilkens C.M.U., Kraan T.C.T.M.v.d.P., Engel M., Aarden L.A., Kapsenberg M.L. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J Immunol. 156:1996;1207-1212.
22. Hayes M.P., Wang J., Norcross M.A. Regulation of interleukin-12 expression in human monocytes, selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood. 86:1995;646-650.
23. Wu J.-Y., Gardiner B.H., Kushner N.K., Pozzi L.M., Kensil C.R., Cloutier P.A., Coughlin R.T., Newman M.J. Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes. Cell Immunol. 154:1994;393-406.
24. Bomford R. Studies on the cellular site of action of the adjuvant activity of saponin for sheep erythocytes. Int Archs Allergy Appl Immun. 67:1982;127-131.
25. Bomford R., Stapleton M., Windsor S., McKnight A., Andronova T. The control of antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants. AIDS Res Hum Retrovir. 8:1992;1765-1770.
26. Cassatella M.A., Meda L., D'Andrea A., Ma A., Trinchieri G. Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol. 25:1995;1-5.
27. Wenner C.A., Guler M.L., Macatonia S.E., O'Garra A., Murphy K.M. Roles of IFN-γ and IFN-α in IL-12 induced T-helper cell-1 development. J Immunol. 156:1996;1442-1447.
28. Heinzel F.P., Rerko R.M., Ling P., Hakami J., Schoenhaut D.S. Interleukin-12 is produced in vivo during endotoxemia and stimulates synthesis of gamma-interferon. Infect Immun. 62:1994;4244-4249.
29. Mattner F., Fischer S., Guckes S., Jin S., Kaulen H., Schmitt E., Rude E., Germann T. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol. 23:1993;2202-2208.
30. Salkowski C.A., Detore G.R., Vogel S.N. Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma-interferon, and interleukin-10 mRNA production in murine macrophages. Infect Immun. 65:1997;3217-3239.
31. Kensil C.R., Wu J.-Y., Soltysik S. Structural and immunological characterization of the vaccine adjuvant QS-21. Powell M.F., Newman M.J., Vaccine design; the subunit and adjuvant approach. 1995;525-539 Plenum Press, New York.